Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 8 |
GO:0110165 | cellular anatomical entity | 1 | 8 |
Related structures:
AlphaFold database: E9AMB6
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 4 | 6 | PF00675 | 0.480 |
CLV_PCSK_KEX2_1 | 192 | 194 | PF00082 | 0.637 |
CLV_PCSK_KEX2_1 | 4 | 6 | PF00082 | 0.481 |
CLV_PCSK_PC1ET2_1 | 192 | 194 | PF00082 | 0.637 |
CLV_PCSK_SKI1_1 | 213 | 217 | PF00082 | 0.635 |
CLV_PCSK_SKI1_1 | 70 | 74 | PF00082 | 0.436 |
DEG_MDM2_SWIB_1 | 123 | 130 | PF02201 | 0.389 |
DOC_MAPK_FxFP_2 | 66 | 69 | PF00069 | 0.642 |
DOC_MAPK_MEF2A_6 | 102 | 109 | PF00069 | 0.637 |
DOC_MAPK_NFAT4_5 | 102 | 110 | PF00069 | 0.635 |
DOC_PP4_FxxP_1 | 66 | 69 | PF00568 | 0.642 |
DOC_USP7_MATH_1 | 207 | 211 | PF00917 | 0.494 |
DOC_USP7_MATH_1 | 21 | 25 | PF00917 | 0.630 |
DOC_USP7_UBL2_3 | 188 | 192 | PF12436 | 0.436 |
DOC_WW_Pin1_4 | 17 | 22 | PF00397 | 0.664 |
LIG_14-3-3_CanoR_1 | 106 | 116 | PF00244 | 0.610 |
LIG_14-3-3_CanoR_1 | 22 | 28 | PF00244 | 0.681 |
LIG_14-3-3_CanoR_1 | 86 | 92 | PF00244 | 0.637 |
LIG_APCC_ABBA_1 | 59 | 64 | PF00400 | 0.636 |
LIG_BRCT_BRCA1_1 | 23 | 27 | PF00533 | 0.617 |
LIG_deltaCOP1_diTrp_1 | 140 | 146 | PF00928 | 0.419 |
LIG_deltaCOP1_diTrp_1 | 182 | 187 | PF00928 | 0.461 |
LIG_deltaCOP1_diTrp_1 | 208 | 219 | PF00928 | 0.469 |
LIG_FHA_1 | 197 | 203 | PF00498 | 0.512 |
LIG_FHA_2 | 78 | 84 | PF00498 | 0.629 |
LIG_FHA_2 | 93 | 99 | PF00498 | 0.592 |
LIG_KLC1_Yacidic_2 | 162 | 167 | PF13176 | 0.411 |
LIG_LIR_Apic_2 | 167 | 172 | PF02991 | 0.423 |
LIG_LIR_Apic_2 | 64 | 69 | PF02991 | 0.641 |
LIG_LIR_Gen_1 | 140 | 151 | PF02991 | 0.422 |
LIG_LIR_Gen_1 | 179 | 189 | PF02991 | 0.492 |
LIG_LIR_Nem_3 | 126 | 130 | PF02991 | 0.338 |
LIG_LIR_Nem_3 | 140 | 146 | PF02991 | 0.383 |
LIG_LIR_Nem_3 | 176 | 181 | PF02991 | 0.483 |
LIG_LIR_Nem_3 | 30 | 35 | PF02991 | 0.734 |
LIG_LIR_Nem_3 | 64 | 68 | PF02991 | 0.642 |
LIG_MYND_3 | 156 | 160 | PF01753 | 0.435 |
LIG_PDZ_Class_1 | 214 | 219 | PF00595 | 0.500 |
LIG_Pex14_1 | 116 | 120 | PF04695 | 0.416 |
LIG_Pex14_2 | 115 | 119 | PF04695 | 0.378 |
LIG_Pex14_2 | 120 | 124 | PF04695 | 0.378 |
LIG_Pex14_2 | 73 | 77 | PF04695 | 0.718 |
LIG_SH2_STAP1 | 181 | 185 | PF00017 | 0.459 |
LIG_SH2_STAT3 | 165 | 168 | PF00017 | 0.438 |
LIG_SH2_STAT5 | 128 | 131 | PF00017 | 0.354 |
LIG_SH2_STAT5 | 165 | 168 | PF00017 | 0.425 |
LIG_SH2_STAT5 | 79 | 82 | PF00017 | 0.638 |
LIG_SH3_3 | 151 | 157 | PF00018 | 0.403 |
LIG_SH3_3 | 50 | 56 | PF00018 | 0.680 |
LIG_SH3_3 | 72 | 78 | PF00018 | 0.642 |
LIG_SH3_4 | 188 | 195 | PF00018 | 0.436 |
LIG_TRAF2_1 | 80 | 83 | PF00917 | 0.626 |
MOD_CDK_SPK_2 | 17 | 22 | PF00069 | 0.718 |
MOD_CK1_1 | 111 | 117 | PF00069 | 0.562 |
MOD_CK1_1 | 12 | 18 | PF00069 | 0.691 |
MOD_CK1_1 | 126 | 132 | PF00069 | 0.241 |
MOD_CK1_1 | 91 | 97 | PF00069 | 0.624 |
MOD_CK2_1 | 46 | 52 | PF00069 | 0.730 |
MOD_CK2_1 | 77 | 83 | PF00069 | 0.629 |
MOD_CK2_1 | 92 | 98 | PF00069 | 0.589 |
MOD_CMANNOS | 116 | 119 | PF00535 | 0.335 |
MOD_GlcNHglycan | 11 | 14 | PF01048 | 0.377 |
MOD_GlcNHglycan | 23 | 26 | PF01048 | 0.538 |
MOD_GlcNHglycan | 38 | 41 | PF01048 | 0.501 |
MOD_GSK3_1 | 107 | 114 | PF00069 | 0.466 |
MOD_GSK3_1 | 17 | 24 | PF00069 | 0.688 |
MOD_GSK3_1 | 77 | 84 | PF00069 | 0.629 |
MOD_GSK3_1 | 88 | 95 | PF00069 | 0.614 |
MOD_GSK3_1 | 9 | 16 | PF00069 | 0.731 |
MOD_N-GLC_1 | 107 | 112 | PF02516 | 0.407 |
MOD_NEK2_1 | 107 | 112 | PF00069 | 0.620 |
MOD_NEK2_1 | 123 | 128 | PF00069 | 0.355 |
MOD_PK_1 | 81 | 87 | PF00069 | 0.639 |
MOD_PKA_2 | 21 | 27 | PF00069 | 0.746 |
MOD_PKA_2 | 85 | 91 | PF00069 | 0.631 |
MOD_Plk_1 | 81 | 87 | PF00069 | 0.639 |
MOD_Plk_1 | 88 | 94 | PF00069 | 0.634 |
MOD_Plk_4 | 111 | 117 | PF00069 | 0.482 |
MOD_Plk_4 | 123 | 129 | PF00069 | 0.335 |
MOD_ProDKin_1 | 17 | 23 | PF00069 | 0.664 |
MOD_SUMO_rev_2 | 30 | 35 | PF00179 | 0.687 |
MOD_SUMO_rev_2 | 71 | 78 | PF00179 | 0.652 |
TRG_ENDOCYTIC_2 | 134 | 137 | PF00928 | 0.382 |
TRG_ENDOCYTIC_2 | 181 | 184 | PF00928 | 0.454 |
TRG_ER_diArg_1 | 3 | 5 | PF00400 | 0.682 |
TRG_ER_diArg_1 | 35 | 38 | PF00400 | 0.713 |
TRG_PTS1 | 216 | 219 | PF00515 | 0.481 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P933 | Leptomonas seymouri | 82% | 99% |
A0A0S4IVJ7 | Bodo saltans | 66% | 100% |
A0A1X0NP20 | Trypanosomatidae | 73% | 100% |
A0A3S5H645 | Leishmania donovani | 92% | 100% |
A4H5A9 | Leishmania braziliensis | 88% | 100% |
A4HTI8 | Leishmania infantum | 91% | 100% |
C9ZPJ6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 72% | 100% |
Q4QID2 | Leishmania major | 96% | 100% |
V5DHY0 | Trypanosoma cruzi | 73% | 100% |